AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as organoid […]
Published findings demonstrate PrimateAI-3D’s ability to improve genetic risk prediction and drug target discovery using primate DNA and advanced artificial intelligence SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in […]
The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany — PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License […]
Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO) Not for use in diagnostic purposes FORT COLLINS, Colo. — GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay […]
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and […]
AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as […]
Company to host webinar featuring tips for managing large-scale proteomics data on UK Biobank Research Analysis Platform MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics […]
New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, CA – Mission Bio, Inc. the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly […]
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and […]
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
